At Investor Conferences

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Amgen (Group)

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, psoriasis, psoriatic arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. *

 

Period Start 1980-01-01 established
Product Industry BIOTECH
     
Region Region Thousand Oaks, CA
  Country United States (USA)
  Street One Amgen Center Drive
  City 91320-1799 Thousand Oaks, CA
  Tel +1-805-447-1000
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
  Currency USD
  Annual sales 14,771,000,000 (revenues, total, consolidated (2007) 2007-12-31)
  Profit 3,166,000,000 (2007-12-31)
  Cash 7,151,000,000 (2007-12-31)
     
    * Document for »About Section«: 
     
   
Record changed: 2023-07-10

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Amgen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top